Symposium / Experience

Joint symposium with the University of Adelaide and the University of Freiburg

The symposium Symposium participants

Nagoya University Graduate School of Medicine, on March 18th, held a joint symposium regarding neuronal and neoplastic disorders together with the University of Adelaide and the University of Freiburg on our campus. The objective of this symposium was to facilitate up-to-date academic exchange with the University of Adelaide and the University of Freiburg, and promote future joint researches. The symposium started off with welcoming remarks by our Dean, Prof. Masahide Takahashi, expressing high expectations.

Executive Dean, Prof. Justin Beilby together with 4 others from the University of Adelaide and Rector, Prof. Hans-Jochen Schiewer together with 3 others from the University of Freiburg attended and participated in presentations from various approaches and disciplines. Many, including graduate students and researchers, participated in the symposium, and were listening intently. The symposium ended with great success, with active Q&A sessions taking place.

On the following 19th and 20th, Strategy Sessions between three Universities were held on our campus and active discussion took place regarding Exchange of medical students, Joint Supervision Program of doctoral candidates and Partnership for exploring the Seeds for research collaboration. After the session, the MOU including Joint Supervision Program of doctoral candidates was signed among three Universities.

We expect this symposium and Strategy Sessions to become an opportunity for more of the three Universities to gain interest each other and to study at each graduate school, promoting further interaction among the three Universities.


Opening Remarks : Prof. Masahide Takahashi: Dean of Graduate School of Medicine & School of Medicine
Guest’s Opening Speech
Prof. Justin Beilby: Executive Dean (Adelaide)
Prof. Michael Wirsching: Chairman, Director of International Affairs (Freiburg)
Prof. Michinari Hamaguchi: President of Nagoya University

Research Presentations
Session1: Oncology I
Session2: Oncology II
Session3: Psycho-oncology and palliative care
Session4: Neuroscience

University of Adelaide Presenters
  • Prof. Andrew Zannettino, M.D., Ph.D.
    University of Adelaide - Cancer Research Now and in the Future (Session 1)
    SAMSN1 is a tumour suppressor gene in multiple myeloma (Session 2)
  • Dr. Daniel Worthley, M.D., Ph.D.
    Gremlin 1 defines a mesenchymal stem cell in the gastrointestinal tract, bone and tumour microenvironment (Session 2)
  • Prof. Jozef Gecz, Ph.D.
    Genetics and Biology of Paediatric Neurological Disorders (Session 4)
University of Freiburg Presenters
  • Prof. Christoph Peters, M.D., Ph.D.
    Basic, Translational and Clinical Cancer Research at the Comprehensive Cancer CenterFreiburg (Session 1)
    Cysteine Cathepsins in Breast Cancer Progression (Session 2)
  • Prof. Michael Wirsching, M.D., Ph.D.
    Psychooncology at the Comprehensive Cancer Center Freiburg (Session 3)
Nagoya University Graduate School of Medicine Presenters
  • Prof. Kenji Kadomatsu, M.D., Ph.D
    Biomedical Research at Nagoya University (Session 1)
  • Prof. Takashi Takahashi, M.D., Ph.D.
    TTF-1/NKX2-1: an enigmatic double-edged sword in lung adenocarcinoma (Session 2)
  • Prof. Atsushi Natsume, M.D., Ph.D.
    Whole exome sequencing reveals the landscape of gene mutations and evolution in low-grade glioma (Session 2)
  • Assoc. Prof. Hiroyuki Kimura, M.D., Ph.D.
    Consultation Liaison Psychiatry: Psychiatric Aspects of Head and Neck Oncology (Session 3)
  • Prof. Branko Aleksic, M.D., Ph.D.
    Analysis of the VAV3 as Candidate Gene for Schizophrenia: Evidences From Voxel-Based Morphometry and Mutation Screening (Session 4)
  • Prof. Kinji Ohno, M.D., Ph.D.
    Physiology of RNA Metabolisms and their Aberrations in Neurological and Neuromuscular Diseases (Session 4)
Top page